Global Ocrelizumab Market Growth 2026-2032
The global Ocrelizumab market size is predicted to grow from US$ 965 million in 2025 to US$ 3378 million in 2032; it is expected to grow at a CAGR of 15.6% from 2026 to 2032.
In 2025, global production of Obinutuzumab reached approximately 8.6 million units.Ocrelizumab is a humanized monoclonal antibody primarily used for the treatment of Multiple Sclerosis (MS), including Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS). It works by targeting and inhibiting the activity of B cells, reducing the immune system's attack on the central nervous system, thereby slowing disease progression and reducing relapses. Ocrelizumab is administered via intravenous injection, typically once every six months. The drug has been approved for clinical use in multiple countries and regions, particularly for MS patients who have not responded well to other treatment options.?
Ocrelizumab is a first-line biologic pharmaceutical drug for the treatment of Multiple Sclerosis (MS), and holds an important position in the global market. With the increasing early diagnosis rates of MS, the demand for effective treatments is steadily rising, leading to growing market demand for Ocrelizumab. Particularly in the treatment of Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS), Ocrelizumab has gradually become a key treatment choice due to its significant efficacy and relatively low side effects.The market prospects for Ocrelizumab are very promising, especially in developed countries and regions, where its excellent efficacy and dosing schedule of once every 6 months greatly improve patient compliance, making it highly favored by both patients and doctors. However, despite its significant therapeutic advantages, the high price of the drug may limit its accessibility in some countries or regions with lower economic conditions.
LP Information, Inc. (LPI) ' newest research report, the ?Ocrelizumab Industry Forecast? looks at past sales and reviews total world Ocrelizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Ocrelizumab sales for 2026 through 2032. With Ocrelizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ocrelizumab industry.
This Insight Report provides a comprehensive analysis of the global Ocrelizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ocrelizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ocrelizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ocrelizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ocrelizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Ocrelizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Ocrelizumab market?
What factors are driving Ocrelizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ocrelizumab market opportunities vary by end market size?
How does Ocrelizumab break out by Type, by Application?
In 2025, global production of Obinutuzumab reached approximately 8.6 million units.Ocrelizumab is a humanized monoclonal antibody primarily used for the treatment of Multiple Sclerosis (MS), including Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS). It works by targeting and inhibiting the activity of B cells, reducing the immune system's attack on the central nervous system, thereby slowing disease progression and reducing relapses. Ocrelizumab is administered via intravenous injection, typically once every six months. The drug has been approved for clinical use in multiple countries and regions, particularly for MS patients who have not responded well to other treatment options.?
Ocrelizumab is a first-line biologic pharmaceutical drug for the treatment of Multiple Sclerosis (MS), and holds an important position in the global market. With the increasing early diagnosis rates of MS, the demand for effective treatments is steadily rising, leading to growing market demand for Ocrelizumab. Particularly in the treatment of Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS), Ocrelizumab has gradually become a key treatment choice due to its significant efficacy and relatively low side effects.The market prospects for Ocrelizumab are very promising, especially in developed countries and regions, where its excellent efficacy and dosing schedule of once every 6 months greatly improve patient compliance, making it highly favored by both patients and doctors. However, despite its significant therapeutic advantages, the high price of the drug may limit its accessibility in some countries or regions with lower economic conditions.
LP Information, Inc. (LPI) ' newest research report, the ?Ocrelizumab Industry Forecast? looks at past sales and reviews total world Ocrelizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Ocrelizumab sales for 2026 through 2032. With Ocrelizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ocrelizumab industry.
This Insight Report provides a comprehensive analysis of the global Ocrelizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ocrelizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ocrelizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ocrelizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ocrelizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Ocrelizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100 mg/10 mL
- 300 mg/10 mL
- Hospital
- Retail
- Online
- Obinutuzumab In Combination With Chlorambucil
- Obinutuzumab Combined With Bendamustine
- Relapsing Remitting Multiple Sclerosis (RRMS)
- Primary Progressive Multiple Sclerosis (PPMS)
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Genentech
- F. Hoffmann-La Roche
- Chugai
What is the 10-year outlook for the global Ocrelizumab market?
What factors are driving Ocrelizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ocrelizumab market opportunities vary by end market size?
How does Ocrelizumab break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ocrelizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ocrelizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ocrelizumab by Country/Region, 2021, 2025 & 2032
2.2 Ocrelizumab Segment by Type
2.2.1 100 mg/10 mL
2.2.2 300 mg/10 mL
2.2.3 Ocrelizumab Sales by Type
2.2.3.1 Global Ocrelizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Ocrelizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Ocrelizumab Sale Price by Type (2021-2026)
2.3 Ocrelizumab Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Ocrelizumab Sales by Sales Channels
2.3.4.1 Global Ocrelizumab Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Ocrelizumab Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Ocrelizumab Sale Price by Sales Channels (2021-2026)
2.4 Ocrelizumab Segment by Combination Therapy
2.4.1 Obinutuzumab In Combination With Chlorambucil
2.4.2 Obinutuzumab Combined With Bendamustine
2.4.3 Ocrelizumab Sales by Combination Therapy
2.4.3.1 Global Ocrelizumab Sales Market Share by Combination Therapy (2021-2026)
2.4.3.2 Global Ocrelizumab Revenue and Market Share by Combination Therapy (2021-2026)
2.4.3.3 Global Ocrelizumab Sale Price by Combination Therapy (2021-2026)
2.5 Ocrelizumab Segment by Application
2.5.1 Relapsing Remitting Multiple Sclerosis (RRMS)
2.5.2 Primary Progressive Multiple Sclerosis (PPMS)
2.5.3 Others
2.5.4 Ocrelizumab Sales by Application
2.5.4.1 Global Ocrelizumab Sale Market Share by Application (2021-2026)
2.5.4.2 Global Ocrelizumab Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Ocrelizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ocrelizumab Breakdown Data by Company
3.1.1 Global Ocrelizumab Annual Sales by Company (2021-2026)
3.1.2 Global Ocrelizumab Sales Market Share by Company (2021-2026)
3.2 Global Ocrelizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Ocrelizumab Revenue by Company (2021-2026)
3.2.2 Global Ocrelizumab Revenue Market Share by Company (2021-2026)
3.3 Global Ocrelizumab Sale Price by Company
3.4 Key Manufacturers Ocrelizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ocrelizumab Product Location Distribution
3.4.2 Players Ocrelizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OCRELIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Ocrelizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Ocrelizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ocrelizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ocrelizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Ocrelizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ocrelizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ocrelizumab Sales Growth
4.4 APAC Ocrelizumab Sales Growth
4.5 Europe Ocrelizumab Sales Growth
4.6 Middle East & Africa Ocrelizumab Sales Growth
5 AMERICAS
5.1 Americas Ocrelizumab Sales by Country
5.1.1 Americas Ocrelizumab Sales by Country (2021-2026)
5.1.2 Americas Ocrelizumab Revenue by Country (2021-2026)
5.2 Americas Ocrelizumab Sales by Type (2021-2026)
5.3 Americas Ocrelizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ocrelizumab Sales by Region
6.1.1 APAC Ocrelizumab Sales by Region (2021-2026)
6.1.2 APAC Ocrelizumab Revenue by Region (2021-2026)
6.2 APAC Ocrelizumab Sales by Type (2021-2026)
6.3 APAC Ocrelizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ocrelizumab by Country
7.1.1 Europe Ocrelizumab Sales by Country (2021-2026)
7.1.2 Europe Ocrelizumab Revenue by Country (2021-2026)
7.2 Europe Ocrelizumab Sales by Type (2021-2026)
7.3 Europe Ocrelizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ocrelizumab by Country
8.1.1 Middle East & Africa Ocrelizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ocrelizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Ocrelizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Ocrelizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ocrelizumab
10.3 Manufacturing Process Analysis of Ocrelizumab
10.4 Industry Chain Structure of Ocrelizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ocrelizumab Distributors
11.3 Ocrelizumab Customer
12 WORLD FORECAST REVIEW FOR OCRELIZUMAB BY GEOGRAPHIC REGION
12.1 Global Ocrelizumab Market Size Forecast by Region
12.1.1 Global Ocrelizumab Forecast by Region (2027-2032)
12.1.2 Global Ocrelizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ocrelizumab Forecast by Type (2027-2032)
12.7 Global Ocrelizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Genentech
13.1.1 Genentech Company Information
13.1.2 Genentech Ocrelizumab Product Portfolios and Specifications
13.1.3 Genentech Ocrelizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Genentech Main Business Overview
13.1.5 Genentech Latest Developments
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Information
13.2.2 F. Hoffmann-La Roche Ocrelizumab Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Ocrelizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 F. Hoffmann-La Roche Main Business Overview
13.2.5 F. Hoffmann-La Roche Latest Developments
13.3 Chugai
13.3.1 Chugai Company Information
13.3.2 Chugai Ocrelizumab Product Portfolios and Specifications
13.3.3 Chugai Ocrelizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chugai Main Business Overview
13.3.5 Chugai Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ocrelizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ocrelizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ocrelizumab by Country/Region, 2021, 2025 & 2032
2.2 Ocrelizumab Segment by Type
2.2.1 100 mg/10 mL
2.2.2 300 mg/10 mL
2.2.3 Ocrelizumab Sales by Type
2.2.3.1 Global Ocrelizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Ocrelizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Ocrelizumab Sale Price by Type (2021-2026)
2.3 Ocrelizumab Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Ocrelizumab Sales by Sales Channels
2.3.4.1 Global Ocrelizumab Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Ocrelizumab Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Ocrelizumab Sale Price by Sales Channels (2021-2026)
2.4 Ocrelizumab Segment by Combination Therapy
2.4.1 Obinutuzumab In Combination With Chlorambucil
2.4.2 Obinutuzumab Combined With Bendamustine
2.4.3 Ocrelizumab Sales by Combination Therapy
2.4.3.1 Global Ocrelizumab Sales Market Share by Combination Therapy (2021-2026)
2.4.3.2 Global Ocrelizumab Revenue and Market Share by Combination Therapy (2021-2026)
2.4.3.3 Global Ocrelizumab Sale Price by Combination Therapy (2021-2026)
2.5 Ocrelizumab Segment by Application
2.5.1 Relapsing Remitting Multiple Sclerosis (RRMS)
2.5.2 Primary Progressive Multiple Sclerosis (PPMS)
2.5.3 Others
2.5.4 Ocrelizumab Sales by Application
2.5.4.1 Global Ocrelizumab Sale Market Share by Application (2021-2026)
2.5.4.2 Global Ocrelizumab Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Ocrelizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ocrelizumab Breakdown Data by Company
3.1.1 Global Ocrelizumab Annual Sales by Company (2021-2026)
3.1.2 Global Ocrelizumab Sales Market Share by Company (2021-2026)
3.2 Global Ocrelizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Ocrelizumab Revenue by Company (2021-2026)
3.2.2 Global Ocrelizumab Revenue Market Share by Company (2021-2026)
3.3 Global Ocrelizumab Sale Price by Company
3.4 Key Manufacturers Ocrelizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ocrelizumab Product Location Distribution
3.4.2 Players Ocrelizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OCRELIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Ocrelizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Ocrelizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ocrelizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ocrelizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Ocrelizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ocrelizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ocrelizumab Sales Growth
4.4 APAC Ocrelizumab Sales Growth
4.5 Europe Ocrelizumab Sales Growth
4.6 Middle East & Africa Ocrelizumab Sales Growth
5 AMERICAS
5.1 Americas Ocrelizumab Sales by Country
5.1.1 Americas Ocrelizumab Sales by Country (2021-2026)
5.1.2 Americas Ocrelizumab Revenue by Country (2021-2026)
5.2 Americas Ocrelizumab Sales by Type (2021-2026)
5.3 Americas Ocrelizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ocrelizumab Sales by Region
6.1.1 APAC Ocrelizumab Sales by Region (2021-2026)
6.1.2 APAC Ocrelizumab Revenue by Region (2021-2026)
6.2 APAC Ocrelizumab Sales by Type (2021-2026)
6.3 APAC Ocrelizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ocrelizumab by Country
7.1.1 Europe Ocrelizumab Sales by Country (2021-2026)
7.1.2 Europe Ocrelizumab Revenue by Country (2021-2026)
7.2 Europe Ocrelizumab Sales by Type (2021-2026)
7.3 Europe Ocrelizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ocrelizumab by Country
8.1.1 Middle East & Africa Ocrelizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ocrelizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Ocrelizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Ocrelizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ocrelizumab
10.3 Manufacturing Process Analysis of Ocrelizumab
10.4 Industry Chain Structure of Ocrelizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ocrelizumab Distributors
11.3 Ocrelizumab Customer
12 WORLD FORECAST REVIEW FOR OCRELIZUMAB BY GEOGRAPHIC REGION
12.1 Global Ocrelizumab Market Size Forecast by Region
12.1.1 Global Ocrelizumab Forecast by Region (2027-2032)
12.1.2 Global Ocrelizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ocrelizumab Forecast by Type (2027-2032)
12.7 Global Ocrelizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Genentech
13.1.1 Genentech Company Information
13.1.2 Genentech Ocrelizumab Product Portfolios and Specifications
13.1.3 Genentech Ocrelizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Genentech Main Business Overview
13.1.5 Genentech Latest Developments
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Information
13.2.2 F. Hoffmann-La Roche Ocrelizumab Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Ocrelizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 F. Hoffmann-La Roche Main Business Overview
13.2.5 F. Hoffmann-La Roche Latest Developments
13.3 Chugai
13.3.1 Chugai Company Information
13.3.2 Chugai Ocrelizumab Product Portfolios and Specifications
13.3.3 Chugai Ocrelizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chugai Main Business Overview
13.3.5 Chugai Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ocrelizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ocrelizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100 mg/10 mL
Table 4. Major Players of 300 mg/10 mL
Table 5. Global Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Ocrelizumab Sales Market Share by Type (2021-2026)
Table 7. Global Ocrelizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ocrelizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Ocrelizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Ocrelizumab Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Ocrelizumab Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Ocrelizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Ocrelizumab Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Ocrelizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players of Obinutuzumab In Combination With Chlorambucil
Table 19. Major Players of Obinutuzumab Combined With Bendamustine
Table 20. Global Ocrelizumab Sales by Combination Therapy (2021-2026) & (Units)
Table 21. Global Ocrelizumab Sales Market Share by Combination Therapy (2021-2026)
Table 22. Global Ocrelizumab Revenue by Combination Therapy (2021-2026) & ($ million)
Table 23. Global Ocrelizumab Revenue Market Share by Combination Therapy (2021-2026)
Table 24. Global Ocrelizumab Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 25. Global Ocrelizumab Sale by Application (2021-2026) & (Units)
Table 26. Global Ocrelizumab Sale Market Share by Application (2021-2026)
Table 27. Global Ocrelizumab Revenue by Application (2021-2026) & ($ million)
Table 28. Global Ocrelizumab Revenue Market Share by Application (2021-2026)
Table 29. Global Ocrelizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Ocrelizumab Sales by Company (2021-2026) & (Units)
Table 31. Global Ocrelizumab Sales Market Share by Company (2021-2026)
Table 32. Global Ocrelizumab Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Ocrelizumab Revenue Market Share by Company (2021-2026)
Table 34. Global Ocrelizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Ocrelizumab Producing Area Distribution and Sales Area
Table 36. Players Ocrelizumab Products Offered
Table 37. Ocrelizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Ocrelizumab Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Ocrelizumab Sales Market Share Geographic Region (2021-2026)
Table 42. Global Ocrelizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Ocrelizumab Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Ocrelizumab Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Ocrelizumab Sales Market Share by Country/Region (2021-2026)
Table 46. Global Ocrelizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Ocrelizumab Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Ocrelizumab Sales by Country (2021-2026) & (Units)
Table 49. Americas Ocrelizumab Sales Market Share by Country (2021-2026)
Table 50. Americas Ocrelizumab Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 52. Americas Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 53. APAC Ocrelizumab Sales by Region (2021-2026) & (Units)
Table 54. APAC Ocrelizumab Sales Market Share by Region (2021-2026)
Table 55. APAC Ocrelizumab Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 57. APAC Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 58. Europe Ocrelizumab Sales by Country (2021-2026) & (Units)
Table 59. Europe Ocrelizumab Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 61. Europe Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Ocrelizumab Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Ocrelizumab Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Ocrelizumab
Table 67. Key Market Challenges & Risks of Ocrelizumab
Table 68. Key Industry Trends of Ocrelizumab
Table 69. Ocrelizumab Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Ocrelizumab Distributors List
Table 72. Ocrelizumab Customer List
Table 73. Global Ocrelizumab Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Ocrelizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Ocrelizumab Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Ocrelizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Ocrelizumab Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Ocrelizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Ocrelizumab Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Ocrelizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Ocrelizumab Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Ocrelizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Ocrelizumab Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Ocrelizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Ocrelizumab Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Ocrelizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Genentech Basic Information, Ocrelizumab Manufacturing Base, Sales Area and Its Competitors
Table 88. Genentech Ocrelizumab Product Portfolios and Specifications
Table 89. Genentech Ocrelizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Genentech Main Business
Table 91. Genentech Latest Developments
Table 92. F. Hoffmann-La Roche Basic Information, Ocrelizumab Manufacturing Base, Sales Area and Its Competitors
Table 93. F. Hoffmann-La Roche Ocrelizumab Product Portfolios and Specifications
Table 94. F. Hoffmann-La Roche Ocrelizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. F. Hoffmann-La Roche Main Business
Table 96. F. Hoffmann-La Roche Latest Developments
Table 97. Chugai Basic Information, Ocrelizumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Chugai Ocrelizumab Product Portfolios and Specifications
Table 99. Chugai Ocrelizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Chugai Main Business
Table 101. Chugai Latest Developments
Table 1. Ocrelizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ocrelizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100 mg/10 mL
Table 4. Major Players of 300 mg/10 mL
Table 5. Global Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Ocrelizumab Sales Market Share by Type (2021-2026)
Table 7. Global Ocrelizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ocrelizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Ocrelizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Ocrelizumab Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Ocrelizumab Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Ocrelizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Ocrelizumab Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Ocrelizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players of Obinutuzumab In Combination With Chlorambucil
Table 19. Major Players of Obinutuzumab Combined With Bendamustine
Table 20. Global Ocrelizumab Sales by Combination Therapy (2021-2026) & (Units)
Table 21. Global Ocrelizumab Sales Market Share by Combination Therapy (2021-2026)
Table 22. Global Ocrelizumab Revenue by Combination Therapy (2021-2026) & ($ million)
Table 23. Global Ocrelizumab Revenue Market Share by Combination Therapy (2021-2026)
Table 24. Global Ocrelizumab Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 25. Global Ocrelizumab Sale by Application (2021-2026) & (Units)
Table 26. Global Ocrelizumab Sale Market Share by Application (2021-2026)
Table 27. Global Ocrelizumab Revenue by Application (2021-2026) & ($ million)
Table 28. Global Ocrelizumab Revenue Market Share by Application (2021-2026)
Table 29. Global Ocrelizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Ocrelizumab Sales by Company (2021-2026) & (Units)
Table 31. Global Ocrelizumab Sales Market Share by Company (2021-2026)
Table 32. Global Ocrelizumab Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Ocrelizumab Revenue Market Share by Company (2021-2026)
Table 34. Global Ocrelizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Ocrelizumab Producing Area Distribution and Sales Area
Table 36. Players Ocrelizumab Products Offered
Table 37. Ocrelizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Ocrelizumab Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Ocrelizumab Sales Market Share Geographic Region (2021-2026)
Table 42. Global Ocrelizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Ocrelizumab Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Ocrelizumab Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Ocrelizumab Sales Market Share by Country/Region (2021-2026)
Table 46. Global Ocrelizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Ocrelizumab Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Ocrelizumab Sales by Country (2021-2026) & (Units)
Table 49. Americas Ocrelizumab Sales Market Share by Country (2021-2026)
Table 50. Americas Ocrelizumab Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 52. Americas Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 53. APAC Ocrelizumab Sales by Region (2021-2026) & (Units)
Table 54. APAC Ocrelizumab Sales Market Share by Region (2021-2026)
Table 55. APAC Ocrelizumab Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 57. APAC Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 58. Europe Ocrelizumab Sales by Country (2021-2026) & (Units)
Table 59. Europe Ocrelizumab Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 61. Europe Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Ocrelizumab Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Ocrelizumab Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Ocrelizumab Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Ocrelizumab Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Ocrelizumab
Table 67. Key Market Challenges & Risks of Ocrelizumab
Table 68. Key Industry Trends of Ocrelizumab
Table 69. Ocrelizumab Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Ocrelizumab Distributors List
Table 72. Ocrelizumab Customer List
Table 73. Global Ocrelizumab Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Ocrelizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Ocrelizumab Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Ocrelizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Ocrelizumab Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Ocrelizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Ocrelizumab Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Ocrelizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Ocrelizumab Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Ocrelizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Ocrelizumab Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Ocrelizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Ocrelizumab Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Ocrelizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Genentech Basic Information, Ocrelizumab Manufacturing Base, Sales Area and Its Competitors
Table 88. Genentech Ocrelizumab Product Portfolios and Specifications
Table 89. Genentech Ocrelizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Genentech Main Business
Table 91. Genentech Latest Developments
Table 92. F. Hoffmann-La Roche Basic Information, Ocrelizumab Manufacturing Base, Sales Area and Its Competitors
Table 93. F. Hoffmann-La Roche Ocrelizumab Product Portfolios and Specifications
Table 94. F. Hoffmann-La Roche Ocrelizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. F. Hoffmann-La Roche Main Business
Table 96. F. Hoffmann-La Roche Latest Developments
Table 97. Chugai Basic Information, Ocrelizumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Chugai Ocrelizumab Product Portfolios and Specifications
Table 99. Chugai Ocrelizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Chugai Main Business
Table 101. Chugai Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ocrelizumab
Figure 2. Ocrelizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ocrelizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Ocrelizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ocrelizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ocrelizumab Sales Market Share by Country/Region (2025)
Figure 10. Ocrelizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100 mg/10 mL
Figure 12. Product Picture of 300 mg/10 mL
Figure 13. Global Ocrelizumab Sales Market Share by Type in 2026
Figure 14. Global Ocrelizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Ocrelizumab Sales Market Share by Sales Channels in 2026
Figure 19. Global Ocrelizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture of Obinutuzumab In Combination With Chlorambucil
Figure 21. Product Picture of Obinutuzumab Combined With Bendamustine
Figure 22. Global Ocrelizumab Sales Market Share by Combination Therapy in 2026
Figure 23. Global Ocrelizumab Revenue Market Share by Combination Therapy (2021-2026)
Figure 24. Ocrelizumab Consumed in Relapsing Remitting Multiple Sclerosis (RRMS)
Figure 25. Global Ocrelizumab Market: Relapsing Remitting Multiple Sclerosis (RRMS) (2021-2026) & (Units)
Figure 26. Ocrelizumab Consumed in Primary Progressive Multiple Sclerosis (PPMS)
Figure 27. Global Ocrelizumab Market: Primary Progressive Multiple Sclerosis (PPMS) (2021-2026) & (Units)
Figure 28. Ocrelizumab Consumed in Others
Figure 29. Global Ocrelizumab Market: Others (2021-2026) & (Units)
Figure 30. Global Ocrelizumab Sale Market Share by Application (2025)
Figure 31. Global Ocrelizumab Revenue Market Share by Application in 2025
Figure 32. Ocrelizumab Sales by Company in 2025 (Units)
Figure 33. Global Ocrelizumab Sales Market Share by Company in 2025
Figure 34. Ocrelizumab Revenue by Company in 2025 ($ millions)
Figure 35. Global Ocrelizumab Revenue Market Share by Company in 2025
Figure 36. Global Ocrelizumab Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Ocrelizumab Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Ocrelizumab Sales 2021-2026 (Units)
Figure 39. Americas Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 40. APAC Ocrelizumab Sales 2021-2026 (Units)
Figure 41. APAC Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 42. Europe Ocrelizumab Sales 2021-2026 (Units)
Figure 43. Europe Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Ocrelizumab Sales 2021-2026 (Units)
Figure 45. Middle East & Africa Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 46. Americas Ocrelizumab Sales Market Share by Country in 2025
Figure 47. Americas Ocrelizumab Revenue Market Share by Country (2021-2026)
Figure 48. Americas Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 49. Americas Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 50. United States Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Ocrelizumab Sales Market Share by Region in 2025
Figure 55. APAC Ocrelizumab Revenue Market Share by Region (2021-2026)
Figure 56. APAC Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 57. APAC Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 58. China Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 62. India Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Ocrelizumab Sales Market Share by Country in 2025
Figure 66. Europe Ocrelizumab Revenue Market Share by Country (2021-2026)
Figure 67. Europe Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 68. Europe Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 69. Germany Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. France Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Ocrelizumab Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 77. Egypt Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Ocrelizumab in 2026
Figure 83. Manufacturing Process Analysis of Ocrelizumab
Figure 84. Industry Chain Structure of Ocrelizumab
Figure 85. Channels of Distribution
Figure 86. Global Ocrelizumab Sales Market Forecast by Region (2027-2032)
Figure 87. Global Ocrelizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Ocrelizumab Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Ocrelizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Ocrelizumab Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Ocrelizumab Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Ocrelizumab
Figure 2. Ocrelizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ocrelizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Ocrelizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ocrelizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ocrelizumab Sales Market Share by Country/Region (2025)
Figure 10. Ocrelizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100 mg/10 mL
Figure 12. Product Picture of 300 mg/10 mL
Figure 13. Global Ocrelizumab Sales Market Share by Type in 2026
Figure 14. Global Ocrelizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Ocrelizumab Sales Market Share by Sales Channels in 2026
Figure 19. Global Ocrelizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture of Obinutuzumab In Combination With Chlorambucil
Figure 21. Product Picture of Obinutuzumab Combined With Bendamustine
Figure 22. Global Ocrelizumab Sales Market Share by Combination Therapy in 2026
Figure 23. Global Ocrelizumab Revenue Market Share by Combination Therapy (2021-2026)
Figure 24. Ocrelizumab Consumed in Relapsing Remitting Multiple Sclerosis (RRMS)
Figure 25. Global Ocrelizumab Market: Relapsing Remitting Multiple Sclerosis (RRMS) (2021-2026) & (Units)
Figure 26. Ocrelizumab Consumed in Primary Progressive Multiple Sclerosis (PPMS)
Figure 27. Global Ocrelizumab Market: Primary Progressive Multiple Sclerosis (PPMS) (2021-2026) & (Units)
Figure 28. Ocrelizumab Consumed in Others
Figure 29. Global Ocrelizumab Market: Others (2021-2026) & (Units)
Figure 30. Global Ocrelizumab Sale Market Share by Application (2025)
Figure 31. Global Ocrelizumab Revenue Market Share by Application in 2025
Figure 32. Ocrelizumab Sales by Company in 2025 (Units)
Figure 33. Global Ocrelizumab Sales Market Share by Company in 2025
Figure 34. Ocrelizumab Revenue by Company in 2025 ($ millions)
Figure 35. Global Ocrelizumab Revenue Market Share by Company in 2025
Figure 36. Global Ocrelizumab Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Ocrelizumab Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Ocrelizumab Sales 2021-2026 (Units)
Figure 39. Americas Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 40. APAC Ocrelizumab Sales 2021-2026 (Units)
Figure 41. APAC Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 42. Europe Ocrelizumab Sales 2021-2026 (Units)
Figure 43. Europe Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Ocrelizumab Sales 2021-2026 (Units)
Figure 45. Middle East & Africa Ocrelizumab Revenue 2021-2026 ($ millions)
Figure 46. Americas Ocrelizumab Sales Market Share by Country in 2025
Figure 47. Americas Ocrelizumab Revenue Market Share by Country (2021-2026)
Figure 48. Americas Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 49. Americas Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 50. United States Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Ocrelizumab Sales Market Share by Region in 2025
Figure 55. APAC Ocrelizumab Revenue Market Share by Region (2021-2026)
Figure 56. APAC Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 57. APAC Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 58. China Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 62. India Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Ocrelizumab Sales Market Share by Country in 2025
Figure 66. Europe Ocrelizumab Revenue Market Share by Country (2021-2026)
Figure 67. Europe Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 68. Europe Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 69. Germany Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. France Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Ocrelizumab Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Ocrelizumab Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Ocrelizumab Sales Market Share by Application (2021-2026)
Figure 77. Egypt Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Ocrelizumab Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Ocrelizumab in 2026
Figure 83. Manufacturing Process Analysis of Ocrelizumab
Figure 84. Industry Chain Structure of Ocrelizumab
Figure 85. Channels of Distribution
Figure 86. Global Ocrelizumab Sales Market Forecast by Region (2027-2032)
Figure 87. Global Ocrelizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Ocrelizumab Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Ocrelizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Ocrelizumab Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Ocrelizumab Revenue Market Share Forecast by Application (2027-2032)
